相关实验视频
Updated: Jan 12, 2026

05:39
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
856
重编程神经瘤交叉通话:新兴的治疗维度和向策略
Qian-Qian Liu1,2, Zi-Kai Dong1, Yong-Fei Wang1
1Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, the First Hospital of Lanzhou University, the First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China.
Military Medical Research
|October 30, 2025
概括
癌症神经科学揭示了神经系统如何影响瘤生长. 准神经瘤相互作用为癌症治疗提供了新的精确疗法.
科学领域:
- 癌症神经科学 癌症神经科学
- 神经瘤学神经瘤学
- 瘤微环境 (TME) 研究
背景情况:
- 神经系统与瘤有动态的相互作用,影响癌症的特征,如扩散和转移.
- 瘤微环境 (TME) 在很大程度上受到双向神经信号的影响.
- 神经剥离研究显示了取决于背景的效应,强调了有针对性的方法的必要性.
研究的目的:
- 审查癌症神经科学的最新进展.
- 提出针对神经与TME相互作用的治疗框架.
- 探索综合神经科学和瘤学的跨学科策略.
主要方法:
- 对神经向治疗的临床前和临床数据的审查.
- 探索药物重用 (例如,β阻断剂,抗精神病药物,抗抑郁药).
- 研究纳米技术支持的有针对性的传递系统.
主要成果:
- 神经与TME相互作用显著调节癌症的进展.
- 神经类型特定和上下文依赖的治疗策略至关重要.
- 神经向疗法显示出提高精度和克服药物耐药性的潜力.
结论:
- 癌症神经科学为理解和准神经瘤交叉通话提供了一个框架.
- 综合神经科学和瘤学的跨学科方法是推动癌症治疗的关键.
- 准神经内置的TME为改善患者护理和治疗结果提供了一个有希望的途径.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

